Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Shen HX, Song YS, Wang HF, Chen C, Song JK, Sun CG, Miao SZ, Chen XG, Bai SL, Zhao YF, Wang K. Comprehensive prognostic value of prealbumin and albumin in hepatocellular carcinoma resection: Insights from a Chinese multicenter cohort. World J Clin Oncol 2026; 17(11): 122944 [DOI: 10.5306/wjco.122944]
Hao-Xin Shen, Yin-Sen Song, Jin-Kun Song, Chen-Guang Sun, Shu-Zhai Miao, Xin-Guo Chen, Yun-Feng Zhao, Organ Transplant Center, The Fifth Clinical Medical College of Henan University of Chinese Medicine/People’s Hospital of Zhengzhou, Zhengzhou 450000, Henan Province, China
Hui-Feng Wang, Department of Hepatobiliary Surgery, The Fifth Clinical Medical College of Henan University of Chinese Medicine/People’s Hospital of Zhengzhou, Zhengzhou 450000, Henan Province, China
Chen Chen, Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, Shaanxi Province, China
Shi-Lei Bai, Kui Wang, Department of Hepatic Surgery II, The Eastern Hepatobiliary Surgery Hospital, Shanghai 200438, China
Co-corresponding authors: Yun-Feng Zhao and Kui Wang.
Author contributions: Shen HX, Song YS, Wang HF, Chen C contributed to conception; Shen HX, Song JK, Sun CG, Miao SZ, Bai SL, Zhao YF, Wang K contributed to study design; Zhao YF, Wang K contributed to administrative support; Shen HX, Song YS, Wang HF, Chen C, Song JK, Sun CG, Miao SZ, Chen XG, Bai SL contributed to data collection and acquisition; Shen HX, Song YS, Wang HF, Bai SL contributed to data analysis; all the authors support the final approval of the manuscript; Zhao YF and Wang K played important and indispensable roles in the manuscript preparation as the co-corresponding authors; Shen HX and Song YS have made crucial and indispensable contributions towards the completion of the project and thus qualified as the co-first authors of the paper.
AI contribution statement: Portions of this manuscript were edited using AI tools solely for language refinement. The authors carefully reviewed and verified all AI-assisted outputs and take full responsibility for the scientific content of the manuscript.
Institutional review board statement: The study was reviewed and approved by the Ethics Committee of Zhengzhou People’s Hospital (No. 2026-ZYLW-009), the Third Affiliated Hospital of Naval Military Medical University, and the First Affiliated Hospital of Xi’an Jiaotong University.
Informed consent statement: All study participants, or their legal guardians, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: All authors have no conflicts of interest or disclosure to declare.
STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement- checklist of items.
Data sharing statement: If necessary, datasets are available from the corresponding author at wangkuiykl@163.com.
Corresponding author: Kui Wang, Academic Fellow, Chief Physician, Full Professor, Department of Hepatic Surgery II, The Eastern Hepatobiliary Surgery Hospital, Shanghai 200433, China. wangkuiykl@163.com
Received: May 7, 2026 Revised: August 12, 2026 Accepted: October 10, 2026 Published online: November 24, 2026 Processing time: 199 Days and 0.1 Hours
Abstract
BACKGROUND
Albumin and prealbumin are established prognostic factors for hepatocellular carcinoma (HCC), but their combined impact on post-resection long-term outcomes requires further clarification.
AIM
To compare the impact of albumin, prealbumin, and their combination on long-term postoperative outcomes in HCC patients.
METHODS
The various impacts of albumin (low < 40 g/L, or normal ≥ 40 g/L) and prealbumin (low < 170 mg/L, or normal ≥ 170 mg/L) on overall survival (OS) and recurrence-free survival (RFS) for HCC patients following partial hepatectomy were comprehensively analyzed using a multi-institutional database.
RESULTS
During a median follow-up of 64.1 months, 892 recurrences and 675 deaths were recorded. Significant differences in OS and RFS were observed across the four groups (all P < 0.001). Compared with Group I (normal albumin and prealbumin), Group II (low albumin, normal prealbumin), Group III (normal albumin, low prealbumin), and Group IV (low albumin and low prealbumin) had shorter OS [Group II: hazard ratio (HR) = 1.37, 95%CI: 1.07-1.76; Group III: HR = 1.89, 95%CI: 1.49-2.39; Group IV: HR = 2.46, 95%CI: 2.02-2.99] and RFS (Group II: HR = 1.25, 95%CI: 1.02-1.54; Group III: HR = 1.65, 95%CI: 1.34-2.02; Group IV: HR = 1.95, 95%CI: 1.64-2.32). Multivariable analysis showed prealbumin was a dominant prognostic predictor for OS and RFS than albumin. When both markers were included, albumin lost independent prognostic value, while low prealbumin (regardless of albumin) remained an independent risk factor for worse OS and RFS. After adjusting for confounders, Group IV had the highest adjusted HR for reduced OS (1.65, 95%CI: 1.34-2.02, P < 0.001) and RFS (1.33, 95%CI: 1.10-1.60, P = 0.002). Time-dependent area under the curve analysis demonstrated that the combined stratification consistently outperformed albumin across all time points (all P < 0.001), with prealbumin showing modestly superior discrimination to albumin.
CONCLUSION
Prealbumin outperforms albumin as a prognostic biomarker for long-term survival after HCC resection. Combining prealbumin and albumin enables precise risk stratification, aiding surgical decision-making and patient counseling. This prealbumin-based risk stratification approach may help optimize perioperative management and identify high-risk patients.
Core Tip: In this multicenter Chinese cohort of 1550 hepatocellular carcinoma patients undergoing curative resection, prealbumin demonstrated superior prognostic value over albumin for overall survival and recurrence-free survival. When both markers were combined, low prealbumin with normal or low albumin independently predicted worse outcomes, whereas isolated low albumin did not. This dual-marker approach enables precise risk stratification to guide surgical decisions and postoperative management.
Citation: Shen HX, Song YS, Wang HF, Chen C, Song JK, Sun CG, Miao SZ, Chen XG, Bai SL, Zhao YF, Wang K. Comprehensive prognostic value of prealbumin and albumin in hepatocellular carcinoma resection: Insights from a Chinese multicenter cohort. World J Clin Oncol 2026; 17(11): 122944
Liver cancer stands as the third most common reason for cancer-induced deaths worldwide, and among all primary liver cancers, hepatocellular carcinoma (HCC) makes up around 90%[1-3]. Partial liver resection remains the main treatment option for early-stage HCC[4,5]. However, postoperative recurrence rates are as high as 70%-80%, resulting in poor long-term survival rates[6-8]. Apart from tumor-related factors, there is growing evidence suggesting that the preoperative nutritional status of HCC patients also affects long-term outcomes after surgery[9-11]. Serum albumin has been routinely employed in clinical practice as an indicator of nutritional status and liver function. Albumin is a critical variable in numerous studies and is frequently utilized in assessments such as Naples prognostic score[12], Child-Pugh grading system, systemic inflammatory score[13], albumin-bilirubin (ALBI) grade[14], controlled nutritional status score[15], and prognostic nutritional index[16,17]. Although albumin is extensively utilized in clinical practice and research, its relatively long half-life often indicates chronic liver diseases and can be significantly affected by external factors, such as exogenous infusion[18]. Prealbumin, also known as transthyretin, is synthesized by the liver and has a relatively short half-life[19-21]. Importantly, prealbumin is a negative acute-phase reactant whose hepatic synthesis is downregulated by pro-inflammatory cytokines during systemic inflammation[22]. Compared with albumin, it exhibits a more rapid response to protein intake and anabolism, serving as a real-time marker rather than reflecting a state from several weeks prior, as albumin does. Thus, prealbumin is increasingly recognized not as a pure “nutritional marker” but as an integrated nutrition-inflammation biomarker that captures the convergence of nutritional status and inflammatory burden. Numerous studies have demonstrated that albumin and prealbumin are factors affecting long-term prognosis[23-25]. However, several studies are based on small sample sizes, and few have concurrently analyzed both nutritional indices[24,26-28].
Given that both albumin and prealbumin involve long-term outcomes in postoperative survival and recurrence, they are likely to have a superimposed effect on the oncologic prognosis for HCC patients after curative resection. Although albumin and prealbumin demonstrate partial collinearity, they possess a certain degree of difference[23]. This observed discrepancy suggests that the combined evaluation of albumin and prealbumin could represent an alternative marker for predicting long-term clinical outcomes.
However, few large-scale multicenter studies have systematically compared the independent and combined prognostic value of preoperative albumin and prealbumin in patients with HCC after curative hepatectomy. To address this gap, we conducted a multicenter retrospective cohort study to evaluate the individual and relative associations of these two markers with long-term oncologic outcomes.
MATERIALS AND METHODS
Patients and study design
This multicenter cohort study consecutively enrolled patients who underwent curative-intent hepatectomy for pathologically confirmed HCC between January 2016 and December 2019. These patients were recruited from three institutions: The Fifth Clinical Medical College of Henan University of Chinese Medicine, the Third Affiliated Hospital of Naval Military Medical University, and the First Affiliated Hospital of Xi’an Jiaotong University.
Eligibility for inclusion required the following: (1) Curative-intent resection; (2) No previous anticancer therapy; and (3) No history of other malignancies. Patients were excluded if they met any of the following: (1) Recurrent HCC; (2) Incomplete preoperative or postoperative medical documentation; (3) Palliative resection due to tumor rupture; (4) Nephrotic syndrome or renal insufficiency; (5) Death within 90 days after surgery; (6) Preoperative intravenous albumin infusion within 7 days before surgery; and (7) Active infection, fever, or overt systemic inflammatory conditions within 1 week before surgery. A detailed participant flow diagram is provided in Supplementary Figure 1. The study obtained approval from the hospital’s ethics committee, and all participants provided informed consent for their data to be used in scientific research.
Clinicopathological characteristics and operative variables
The assessment of risk factors for overall survival (OS) and recurrence-free survival (RFS) included patient conditions and tumor characteristics. Demographic data and clinical laboratory results encompassed age, sex, body mass index, hypertension, diabetes, alcohol consumption, American Society of Anesthesiologists score, hepatitis B virus (HBV) status, cirrhosis, Child-Pugh grade, portal hypertension (defined as esophageal varices or splenomegaly with a platelet count ≤ 100 × 109/L), total bilirubin, preoperative serum alanine aminotransferase, aspartate aminotransferase, and preoperative serum α-fetoprotein (AFP) levels. Tumor-related variables encompassed maximum tumor diameter, tumor number (solitary or multiple), microvascular invasion[29], the presence of satellite lesions, tumor differentiation grade, tumor encapsulation status, and Barcelona Clinic Liver Cancer (BCLC) stage. Operative variables comprised operation duration, intraoperative blood loss, the requirement for intraoperative blood transfusion, the extent of hepatectomy (minor or major; major hepatectomy is defined as removing three or more Couinaud segments, whereas minor hepatectomy involves removing fewer than three segments), type of liver resection (anatomical, following the Brisbane 2000 anatomical classification[30], or non-anatomical like wedge or limited resection), and resection margin status. Cirrhosis and tumor-related factors were identified using postoperative pathology and imaging modalities: Abdominal ultrasonography, contrast-enhanced computed tomography (CT), and abdominal magnetic resonance imaging (MRI). All laboratory parameters, including albumin and prealbumin, were measured from blood samples obtained within 7 days before surgery at each participating center. The cut-off values of 40 g/L for albumin and 170 mg/L for prealbumin were both derived from previously published HCC prognostic studies[23,31-33].
Follow-up and primary outcomes
Follow-up for patients was conducted at their respective hospitals, adhering to personalized surveillance protocols established by the collaborating institutions. Post-discharge, surveillance included testing for AFP and Des-gamma-carboxy prothrombin (DCP) levels, along with ultrasonography, CT scans, and abdominal MRI. Surveillance was performed at the following intervals: Every 2-3 months during the initial 6 months, every 3-4 months for the subsequent 18 months, and every 6 months after that period. Upon suspicion of HCC recurrence, diagnostic modalities including contrast-enhanced CT, MRI, bone scans, and positron emission tomography/CT scans were conducted as clinically indicated. Tumor recurrence was identified by the development of intra- or extra-hepatic nodules, potentially accompanied by elevated AFP or DCP levels. These intrahepatic nodules exhibited radiological characteristics consistent with HCC on contrast-enhanced CT or MRI. For HCC patients, diagnosis followed the American Association for the Study of Liver Diseases criteria (i.e., arterial phase hyperenhancement with washout on venous/delayed phases). All scans were interpreted by experienced radiologists (≥ 5 years) at each participating center. Patients with recurrent tumors underwent active therapies, comprising re-resection, salvage transplantation, transcatheter arterial chemoembolization (TACE), percutaneous ablation, radiotherapy, targeted therapy, and immunotherapy, either singly or in combination, or conservative management. The primary outcomes evaluated in this study were OS and RFS. OS referred to the time from the surgical date to death from any cause or the last follow-up. RFS was determined as the duration from surgery to the first episode of HCC recurrence, all-cause death, or the final follow-up.
Statistical analysis
Categorical variables were reported as n (%) while continuous variables were expressed as mean ± SD or median (range), depending on data distribution. For categorical variables, differences between groups were analyzed using the χ² test. Continuous variables were analyzed using the Student’s t-test or Mann-Whitney U test, depending on suitability. The Kaplan-Meier method was used to estimate OS and RFS, and the log-rank test was employed to compare these survival outcomes. To evaluate and compare the prognostic discrimination performance of albumin, prealbumin, and their combined stratification, we performed timedependent receiver operating characteristic (ROC) curve analysis. The area under the timedependent ROC curve (AUC) was calculated at 1, 2, 3, 4, and 5year time points for each of the three markers. Time-dependent AUCs were compared using DeLong’s nonparametric test. Restricted cubic spline analyses with four knots were performed to explore the potential non-linear associations of preoperative albumin and prealbumin levels with OS and RFS, and P values for non-linearity were calculated. Multivariate analysis followed a two-step process: Initially, all factors with a univariate P-value < 0.1 that correlated with OS or RFS were included. Subsequently, multivariate regression analyses using forward stepwise selection based on the likelihood-ratio test were conducted to determine risk predictors for OS and RFS post-hepatic resection for HCC. R version 4.3.1 was used for statistical analyses. All statistical tests were two-tailed, with statistical significance established at P < 0.05.
RESULTS
Comparisons of clinicopathologic characteristics
From a multicenter database, we enrolled 1550 patients who had undergone curative hepatic resection for HCC, in line with the predefined inclusion criteria. Based on their prealbumin and albumin levels, these patients were divided into four groups: Group I, patients with a normal prealbumin and albumin (n = 1029); Group II, a normal prealbumin and low albumin (n = 157); Group III, a low prealbumin and normal albumin (n = 154); and Group IV, a low prealbumin and albumin (n = 210). The detailed grouping is shown in Figure 1. Table 1 provides a comparative analysis of the clinicopathologic characteristics and operative variables of the four respective groups.
Table 2 displays the long-term postoperative oncological outcomes corresponding to these four patient groups. With a median follow-up duration of 64.1 months, HCC recurrence occurred in 892 patients, while mortality was observed in 675 patients. Significant differences in recurrence and OS rates were observed among the four groups (all P < 0.001). HCC patients with varying nutritional status were more likely to experience initial postoperative recurrence at BCLC stage A. Additionally, the rates of extrahepatic metastasis were similar across the four groups. While the overall mortality rates varied significantly among the groups, the non-cancer-related mortality rates for these patients were comparable. Figure 2 demonstrates Kaplan-Meier curves for OS and RFS in HCC patients after surgery, stratified by different levels of preoperative albumin and prealbumin, with all log-rank P < 0.001. Figure 3 compares OS and RFS curves, respectively, across the four nutritional status groups. Compared with Group I, Group II [hazard ratio (HR) = 1.37, 95%CI: 1.07-1.76, P = 0.013], Group III (HR = 1.89, 95%CI: 1.49-2.39, P < 0.001), and Group IV (HR = 2.46, 95%CI: 2.02-2.99, P < 0.001) had significantly shorter OS after curative hepatectomy. Similarly, Groups II-IV showed decreased RFS vs Group I (HR = 1.25, 95%CI: 1.02-1.54, P = 0.033; HR = 1.65, 95%CI: 1.34-2.02, P < 0.001; HR = 1.95, 95%CI: 1.64-2.32, P < 0.001). Time-dependent AUC analysis (Figure 4) demonstrated that the combined albumin-prealbumin stratification consistently outperformed albumin alone at all time points for both OS and RFS (all P < 0.001), and showed superior or comparable performance to prealbumin alone. Direct comparison between albumin and prealbumin revealed that prealbumin tended to have higher AUC values across most time points, with statistically significant differences observed at 1, 3, and 4 years for RFS (P = 0.024, 0.011, and 0.034) and at 4 years for OS (P = 0.004). Overall, prealbumin exhibited a modest but consistent advantage over albumin in prognostic discrimination (Supplementary Table 1). Restricted cubic spline analyses showed no significant non-linear association between albumin and either OS or RFS (both P for non-linearity > 0.05), whereas a significant non-linear association was observed between prealbumin and RFS (P for non-linearity = 0.0082; Supplementary Figure 2).
Figure 2 Comparisons of overall survival and recurrence-free survival curves according to different albumin levels and prealbumin levels.
A and B: Albumin levels; C and D: Prealbumin levels.
Figure 4 Time-dependent receiver operating characteristic curves for albumin, prealbumin, and the combined albumin-prealbumin stratification in predicting overall survival and recurrence-free survival.
A: Overall survival; B: Recurrence-free survival. AUC: Area under the curve.
Table 2 Long-term outcomes after excluding postoperative early deaths, n (%)/mean ± SD.
Univariable and multivariable analyses of OS and RFS
The univariable Cox-regression analyses for OS and RFS following curative liver resection for HCC are shown in Table 3. Variables demonstrating statistical significance (P < 0.1) on univariable analysis were subsequently included in the multivariable analysis, as detailed in Tables 4 and 5. In Model 1, the HR of albumin level below 40 g/L on the risk of reduced OS and RFS were 1.35 (95%CI: 1.14-1.59) and 1.19 (95%CI: 1.02-1.36), respectively. In Model 2, the HR of prealbumin level below 170 mg/L, with respect to the risk of decreased OS and RFS, were 1.47 (95%CI: 1.24-1.74) and 1.30 (95%CI: 1.12-1.51), respectively. In Model 3, albumin was not an independent risk factor for OS and RFS when both albumin and prealbumin were included in multivariable analysis. In Model 4, two subgroups were independent risk factors for worse OS and RFS: (1) low prealbumin and normal albumin (OS: HR = 1.41, 95%CI: 1.11-1.79, P = 0.005; RFS: HR = 1.30, 95%CI: 1.06-1.60, P = 0.014); and (2) low prealbumin and low albumin (OS: HR = 1.65, 95%CI: 1.34-2.02, P < 0.001; RFS: HR = 1.33, 95%CI: 1.10-1.60, P = 0.002).
Table 3 Univariable Cox regression analyses for overall survival and recurrence-free survival.
In our large cohort study, we evaluated the effects of albumin, prealbumin, and their combined use on the long-term prognosis of patients with HCC who received curative surgical resection. The results demonstrate that reduced albumin and prealbumin levels are independently associated with unfavorable OS and RFS, with prealbumin showing greater predictive value relative to albumin. Stratification of HCC patients according to preoperative albumin and prealbumin status may facilitate more refined risk assessment and inform discussions regarding postoperative surveillance intensity.
Several previous studies have confirmed that the preoperative albumin concentration is closely linked to the prognosis of HCC after treatment modalities such as hepatic resection, radiofrequency ablation, transarterial embolization, TACE, and external beam radiation therapy. We deliberately focused on patients undergoing hepatectomy rather than TACE, ablation, or systemic therapy, because hepatic resection imposes substantially greater surgical trauma, metabolic stress, and demands on liver regeneration capacity than other modalities. This high-metabolic-burden setting maximizes the prognostic relevance of baseline nutritional-inflammatory markers, enabling clearer detection of their association with long-term outcomes. In addition, a consistent feature across these studies is that the albumin concentration was defined with a cutoff value of 35 g/L, which is based on the Child-Pugh grading system. Given the susceptibility of preoperative albumin levels to various factors, if we define albumin as 35 g/L, there may be more patients whose grouping is changed by exogenous infusion of albumin or plasma. Consequently, we set a cut-off value of 40 g/L for the serum albumin index, thereby raising the threshold and mitigating the potential influence of peripheral supplemental infusions on our study outcomes. In this study, we found that albumin, at the routinely used diagnostic cut-off of 40 g/L, showed a significant correlation with the OS and RFS in patients who underwent hepatectomy, consistent with the results published by Wang et al[33].
Despite albumin’s extensive use in clinical settings, multiple investigations have shown that prealbumin offers superior sensitivity and specificity for the prediction of long-term prognosis in patients with HCC[23]. Wen et al[34] put forward the integration of serum prealbumin into the Child-Pugh grade system, giving rise to the modified Child-Pugh grade system. Comprising four key indicator-prealbumin, albumin, total bilirubin, and prothrombin time-this modified system has the potential to enhance the accuracy of predicting survival in HCC patients following surgical resection. Li et al[35] developed the prealbumin-bilirubin score based on prealbumin and bilirubin levels; this score demonstrates strong stratification capabilities and exceptional predictive accuracy, which is superior to both the ALBI score and Child-Pugh grade system. Our multivariable regression analysis of Models 1 and 2 revealed that prealbumin was a stronger predictor of risk compared to albumin. Furthermore, the peripheral administration of human serum albumin solution or blood transfusion seemingly does not significantly impact prealbumin. Hence, prealbumin is a preferred option for hospitals routinely performing prealbumin tests, whereas albumin serves as a viable alternative for hospitals lacking such test capability. Notably, upon including both albumin and prealbumin in the multivariable regression model, albumin failed to emerge as an independent risk factor for OS and RFS. As reflected in Model 3, this outcome is likely a consequence of the positive correlation existing between albumin and prealbumin[23,34]. To further evaluate the relative contributions of albumin and prealbumin, we stratified patients into four groups based on distinct preoperative albumin and prealbumin levels. Kaplan-Meier curves demonstrated that these four groups were significantly associated with long-term outcomes (all log-rank P < 0.001). However, formal statistical comparisons using Wald tests revealed two important findings. First, Group II (low albumin with normal prealbumin) did not differ significantly from Group I (normal albumin and prealbumin), indicating that isolated low albumin without prealbumin reduction carries no independent prognostic risk. Second, Group III (low prealbumin with normal albumin) and Group IV (low prealbumin with low albumin) showed nearly identical HRs and did not differ significantly from each other. Collectively, these results demonstrate that the prognostic signal in the four-group stratification is predominantly driven by prealbumin, regardless of whether albumin is normal or reduced. This finding has important clinical implications. Prealbumin has a half-life of 2-3 days, whereas albumin has a half-life of 19-20 days, meaning that albumin levels can be maintained within the normal range during the perioperative period via exogenous albumin infusion. However, our data suggest that such exogenous supplementation-while potentially improving short-term nutritional status and reducing postoperative complications-does not alter the long-term prognostic trajectory determined by the patient’s baseline prealbumin level, which reflects underlying fitness, inflammatory burden, and hepatic reserve of HCC patients.
The proportion of patients with cirrhosis and portal hypertension increased progressively from group I to group IV, indicating a deterioration in liver function. Additionally, our analysis revealed that the prevalence of HBV infection among patients in groups I and II was significantly lower compared with that in groups III and IV. This discrepancy may be attributed to the differing levels of prealbumin, rather than albumin. This observation aligns with the established biology of prealbumin as a negative acute-phase reactant[22]. Its hepatic synthesis is transcriptionally suppressed by interleukin-6 and tumor necrosis factor-alpha during inflammation, meaning that low prealbumin reflects not only nutritional depletion but also the systemic inflammatory burden driven by chronic HBV infection and tumor biology. Indeed, recent literature has emphasized that serum proteins such as prealbumin and albumin should be interpreted as markers of inflammation rather than as isolated measures of nutritional status. In the context of HBV-related HCC, the higher prevalence of HBV infection in Groups III and IV-combined with the progressive increase in cirrhosis and portal hypertension from Group I to Group IV-supports the interpretation that low prealbumin captures a composite signal of hepatic dysfunction, inflammatory activation, and compromised nutritional reserve, rather than pure malnutrition[36-39]. Antiviral treatment may enhance preoperative nutritional status by controlling inflammatory stimulation induced by HBV. Improved preoperative serum prealbumin levels following these measures may indicate a better prognosis.
Several specific limitations have been identified in this study, and as such, its results should be interpreted with caution. Firstly, this retrospective study is subject to certain inherent biases, such as unidentifiable confounders, as well as patient loss to follow-up. As a three-center retrospective study, variations in laboratory platforms, reagents, and reference ranges for albumin and prealbumin measurements may exist across institutions, which could potentially introduce measurement heterogeneity. Secondly, the difference of OS may be influenced by the financial situation of HCC patients, especially of those with severe cirrhosis[40]. Third, since our cohort was derived from Chinese medical centers with a predominance of HBV-related HCC cases, the results may not be extrapolated to Western populations, where the etiological drivers of HCC differ substantially. Fourth, although we collected data on post-recurrence treatments, we did not incorporate them as time-dependent covariates in the primary Cox model to avoid guarantee-time bias. Nevertheless, heterogeneity in post-recurrence management across centers and over time may have influenced OS after recurrence, which represents an inherent limitation of long-term retrospective cohorts. Future prospective studies with standardized post-recurrence treatment protocols are warranted to validate our findings.
CONCLUSION
Prealbumin is a sensitive prognostic index that is associated with long-term outcomes after HCC resection. Its role as a negative acute-phase reactant may be particularly relevant in HBV-related HCC, where chronic inflammation is a key driver of disease progression. Preoperative albumin and prealbumin status can stratify patients into distinct prognostic risk categories, which may assist in clinical risk assessment and guide the design of future prospective studies. The clinical utility of prealbumin-based interventions requires further validation.
Johnson PJ, Berhane S, Kagebayashi C, Satomura S, Teng M, Reeves HL, O'Beirne J, Fox R, Skowronska A, Palmer D, Yeo W, Mo F, Lai P, Iñarrairaegui M, Chan SL, Sangro B, Miksad R, Tada T, Kumada T, Toyoda H. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade.J Clin Oncol. 2015;33:550-558.
[RCA] [PubMed] [DOI] [Full Text][Cited by in Crossref: 2296][Cited by in RCA: 2351][Article Influence: 213.7][Reference Citation Analysis (7)]
Li JD, Xu XF, Han J, Wu H, Xing H, Li C, Yu JJ, Zhou YH, Gu WM, Wang H, Chen TH, Zeng YY, Lau WY, Wu MC, Shen F, Yang T. Preoperative prealbumin level as an independent predictor of long-term prognosis after liver resection for hepatocellular carcinoma: a multi-institutional study.HPB (Oxford). 2019;21:157-166.
[RCA] [PubMed] [DOI] [Full Text][Cited by in Crossref: 35][Cited by in RCA: 41][Article Influence: 5.9][Reference Citation Analysis (5)]
Li C, Wang MD, Sun XD, Diao YK, Yao LQ, Wang H, Liang YJ, Zhou YH, Gu WM, Chen TH, Chen Z, Gu LH, Shen F, Lv GY, Yang T, Huang DS. Development and validation of prealbumin-bilirubin score (preALBI score) for predicting long-term survival after hepatectomy for hepatocellular carcinoma: A multicenter analysis versus ALBI score.Am J Surg. 2024;232:87-94.
[RCA] [PubMed] [DOI] [Full Text][Cited by in Crossref: 3][Cited by in RCA: 4][Article Influence: 2.0][Reference Citation Analysis (0)]